anmelden
SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.09.17 | Roche Underperform | BNP PARIBAS | |
| 25.09.17 | Roche overweight | JP Morgan Chase & Co. | |
| 21.09.17 | Roche buy | Jefferies & Company Inc. | |
| 21.09.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.09.17 | Novartis kaufen | HSBC | |
| 15.09.17 | Roche Reduce | HSBC | |
| 13.09.17 | Roche overweight | Barclays Capital | |
| 13.09.17 | Roche overweight | JP Morgan Chase & Co. | |
| 12.09.17 | Roche Hold | Baader Bank | |
| 12.09.17 | Roche Reduce | HSBC | |
| 11.09.17 | Roche Hold | Deutsche Bank AG | |
| 11.09.17 | Roche overweight | JP Morgan Chase & Co. | |
| 11.09.17 | Roche overweight | JP Morgan Chase & Co. | |
| 11.09.17 | Roche Hold | Kepler Cheuvreux | |
| 11.09.17 | Roche Outperform | Credit Suisse Group | |
| 11.09.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 07.09.17 | Novartis buy | HSBC | |
| 05.09.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.09.17 | Roche Neutral | UBS AG | |
| 29.08.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 28.08.17 | Novartis Neutral | UBS AG | |
| 28.08.17 | Novartis buy | Kepler Cheuvreux | |
| 24.08.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.08.17 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.08.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.08.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 04.08.17 | Novartis buy | Baader Bank | |
| 31.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 28.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 28.07.17 | Roche Hold | Deutsche Bank AG | |
| 27.07.17 | Roche Neutral | UBS AG | |
| 27.07.17 | Roche Outperform | Bernstein Research | |
| 26.07.17 | Novartis overweight | Morgan Stanley | |
| 26.07.17 | Roche Equal-Weight | Morgan Stanley | |
| 24.07.17 | Novartis buy | Jefferies & Company Inc. | |
| 20.07.17 | Roche overweight | JP Morgan Chase & Co. | |
| 20.07.17 | Novartis Neutral | UBS AG | |
| 20.07.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.07.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.07.17 | Novartis Outperform | Bernstein Research |